Journal article
The efficacy and safety of sevelamer and lanthanum versus calcium-containing and iron-based binders in treating hyperphosphatemia in patients with chronic kidney disease: a systematic review and meta-analysis
Abstract
Background: It remains unclear which phosphate binders should be preferred for hyperphosphatemia management in chronic kidney disease (CKD).
Methods: We performed a systematic review and meta-analysis of randomized trials comparing sevelamer or lanthanum with other phosphate binders in CKD.
Authors
Habbous S; Przech S; Acedillo R; Sarma S; Garg AX; Martin J
Journal
Nephrology Dialysis Transplantation, Vol. 32, No. 1, pp. 111–125
Publisher
Oxford University Press (OUP)
Publication Date
January 1, 2017
DOI
10.1093/ndt/gfw312
ISSN
0931-0509